Related Experiment Video
Updated: Apr 30, 2026

Detecting the Lyme Disease Spirochete, Borrelia Burgdorferi, in Ticks Using Nested PCR
Published on: February 4, 2018
Bartonella henselae: A challenging diagnosis with a bright future
Thayná Laner Cardoso1, Jênifer Malheiros Gonçalves2, Daiane Drawanz Hartwig1
1Laboratório de Bacteriologia e Bioensaios (LaBBio), Departamento de Microbiologia e Parasitologia, Instituto de Biologia, Universidade Federal de Pelotas, Capão do Leão, Rio Grande Do Sul, Brazil; Programa de Pós-Graduação em Biotecnologia, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, RS, Brazil.
Diagnosing Bartonella henselae (B. henselae) infection, the cause of Cat Scratch Disease (CSD), is difficult due to unreliable conventional methods. Recombinant protein assays show promise for more accurate diagnosis.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Bartonella henselae causes Cat Scratch Disease (CSD), a zoonotic infection with cats as reservoirs.
- CSD can cause severe complications, especially in immunocompromised individuals.
- Current diagnostic methods for B. henselae infection lack sensitivity, specificity, and standardization, often showing cross-reactivity.
Purpose of the Study:
- To critically assess current diagnostic techniques for B. henselae.
- To highlight the limitations of existing diagnostic methods.
- To explore innovative strategies using recombinant antigens for improved serological diagnosis.
Main Methods:
- Review of current literature on B. henselae diagnostic techniques.
- Analysis of limitations including sensitivity, specificity, and cross-reactivity.
- Exploration of recombinant protein-based assays as an alternative approach.
Main Results:
- Conventional methods like culture, ELISA, IFA, and PCR have significant limitations.
- Serological assays often cross-react with other pathogens (e.g., Chlamydia pneumoniae, Coxiella burnetii).
- Recombinant protein assays offer potential for enhanced specificity and reproducibility.
Conclusions:
- There is a critical need for improved diagnostic methods for B. henselae infections.
- Recombinant antigen-based assays represent a promising advancement for accurate serological diagnosis.
- Further development of these novel assays is crucial for effective CSD management.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Bacterial Phylum Spirochaetes
Bacterial Meningitis I: Introduction

